Time for new indications for statins?
The role of statins in the treatment and prevention of cardiovascular diseases, such as coronary artery disease, acute coronary syndromes, diabetes or stroke is well established. However, there are still some questions regarding the role of statins in patients with heart failure, hypertension, atrial fibrillation and chronic kidney disease (CKD). This editorial review discusses the current evidence regarding the use of statins in patients with hypertension (with or without dyslipidemia) or CKD. We need new large randomized clinical trials to confirm the potentially beneficial positive results obtained so far.
Banach
Maciej
M
Department of Hypertension, Medical University of Łódź, Łódź, Poland. maciejbanach@aol.co.uk
Mikhailidis
Dimitri P
DP
Kjeldsen
Sverre E
SE
Rysz
Jacek
J
D001794:Blood Pressure / Q000187:drug effects; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000517:prevention & control; D002784:Cholesterol / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006973:Hypertension / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000188:drug therapy*; D008077:Lipoproteins, LDL / Q000097:blood
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008077:Lipoproteins, LDL; D002784:Cholesterol